# Raer Therapeutics Ltd

## Details

- **Company number:** [SC828508](https://find-and-update.company-information.service.gov.uk/company/SC828508)
- **Status:** active
- **Type:** ltd
- **Incorporated:** 11 Nov 2024
- **Registered office:** 43 HYNDLAND RD, FLAT 0/1, GLASGOW, G12 9UX
- **Nature of business:** [72110](/sic/72110) Research and experimental development on biotechnology



## Officers

| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HADWIN, James | director | 1 Mar 2025 | 30 Jun 2025 |
| TOWART, Laura Anne | director | 11 Nov 2024 |  |
| MCNALLY, Nathan | director | 11 Nov 2024 |  |
| CAGAN, Ross Leigh, Prof | director | 11 Nov 2024 |  |



## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Mr James Hadwin | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 1 Mar 2025 | 30 Jun 2025 |
| Prof Ross Leigh Cagan | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent, right-to-appoint-and-remove-directors | 11 Nov 2024 |  |
| Ms Laura Anne Towart | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent, right-to-appoint-and-remove-directors | 11 Nov 2024 |  |
| Mr Nathan Mcnally | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent, right-to-appoint-and-remove-directors | 11 Nov 2024 |  |



## Accounts

| Year ended | Net assets | Cash |
|---|---|---|
| 30 Nov 2025 | £3 | £3 |